Cutaneous Malignant Melanoma Presenting as an Isolated Splenic Metastasis: An Update

被引:1
作者
Alshehri, Saeed Ali [1 ]
Hussein, Toka M. R. A. [2 ]
Hussein, Mahmoud R. A. [3 ]
机构
[1] Armed Forces Hosp, Dept Pathol & Lab Med, Sect Biochem, Khamis Mushait, Saudi Arabia
[2] Sohag Univ, Fac Med, Sohag, Egypt
[3] Assiut Univ, Fac Med, Dept Pathol, Assiut, Egypt
关键词
Melanoma; Spleen; Isolated; Metastasis; Skin; Single mass; SPLEEN; PATIENT; GROWTH; SURVIVAL; RUPTURE; MARKERS;
D O I
10.14740/wjon1567
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although the spleen is a highly vascularized organ, metastatic de-posits from non-hematolymphoid solid malignancies are rare. This is reasoned to the inherent resistance of the splenic parenchyma to har-bor metastases. The splenic capsule, lack of afferent lymphatics, con-tractile properties of the spleen, and the angular and gyroid course of the splenic artery form several barriers against the metastatic spread of malignant tumors. Moreover, the immune cells in the white and red pulps of the spleen have strong defensive ability against the tumor cells. Metastasis from solid tumors to the spleen often occurs only during widespread distant spread. Malignant melanoma is a rare but fatal malignancy. Isolated splenic metastasis from malignant melano-ma is exceptionally rare. Studies that addressed the splenic metastasis from cutaneous malignant melanoma are scarce. This minireview was performed to address this subject. Here we present an overview of the clinicopathologic features of isolated splenic metastatic melanoma. The diagnostic biochemical markers in melanoma are also discussed.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 34 条
[1]   LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951) [J].
Agarwala, Sanjiv S. ;
Keilholz, Ulrich ;
Gilles, Erard ;
Bedikian, Agop Y. ;
Wu, Jane ;
Kay, Richard ;
Stein, Cy A. ;
Itri, Loretta M. ;
Suciu, Stefan ;
Eggermont, Alexander M. M. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) :1807-1814
[2]  
BARBERAGUILLEM E, 1989, CANCER RES, V49, P4003
[3]  
BERGE T, 1974, ACTA PATH MICRO IM A, VA 82, P499
[4]   Systemic administration of a recombinant adenovirus encoding a HSA-angiostatin kringle 1-3 conjugate inhibits MDA-MB-231 tumor growth and metastasis in a transgenic model of spontaneous eye cancer [J].
Bouquet, C ;
Frau, E ;
Opolon, P ;
Connault, E ;
Abitbol, M ;
Griscelli, F ;
Yeh, P ;
Perricaudet, M .
MOLECULAR THERAPY, 2003, 7 (02) :174-184
[5]   Serological markers for melanoma [J].
Brochez, L ;
Naeyaert, JM .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (02) :256-268
[6]   SPONTANEOUS RUPTURE OF SPLEEN IN A PATIENT WITH SPLENIC METASTASIS OF MELANOMA - A CASE-REPORT [J].
BUZBEE, TM ;
LEGHA, SS .
TUMORI, 1992, 78 (01) :47-48
[7]  
Compérat E, 2007, ARCH PATHOL LAB MED, V131, P965
[8]   Surgical aspects of splenic disease and lymphoma [J].
Coon, WW .
CURRENT PROBLEMS IN SURGERY, 1998, 35 (07) :548-646
[9]  
Deichmann M, 2000, J EXP CLIN CANC RES, V19, P301
[10]   S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma [J].
Deichmann, M ;
Benner, A ;
Bock, M ;
Jäckel, A ;
Uhl, K ;
Waldmann, V ;
Näher, H .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (06) :1891-1896